NOF (4403) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
5 Aug, 2026Executive summary
Net sales for the three months ended June 30, 2026, rose 23.1% year-over-year to ¥69,007 million, driven by strong performance in Functional Chemicals and Explosives & Propulsion, despite a challenging global environment.
Operating profit declined 9.7% year-over-year to ¥10,695 million, and profit attributable to owners of parent fell 12.1% to ¥7,571 million, reflecting higher costs and segment-specific challenges.
The company is executing its 2028 Mid-Term Management Plan, focusing on business expansion, new technologies, productivity, safety, and CSR.
Financial highlights
Net sales: ¥69,007 million (+23.1% YoY); Operating profit: ¥10,695 million (−9.7% YoY); Ordinary profit: ¥11,505 million (−6.3% YoY); Profit attributable to owners of parent: ¥7,571 million (−12.1% YoY).
Basic earnings per share: ¥33.53 (vs. ¥37.00 last year).
Comprehensive income: ¥10,562 million (vs. ¥11,368 million last year).
Total assets: ¥382,306 million (down ¥16,861 million from March 31, 2026); Net assets: ¥294,345 million.
Outlook and guidance
Full-year forecast (ending March 31, 2027): Net sales ¥319,000 million (+23.7% YoY), Operating profit ¥50,000 million (+5.5% YoY), Profit attributable to owners of parent ¥39,000 million (−3.8% YoY), EPS ¥169.60.
No change to previously announced forecasts; continued monitoring of geopolitical and raw material risks.
Dividend forecast for FY2027: ¥70 per share (up from ¥61 in FY2026).
Latest events from NOF
- Explosives & Propulsion drove record profits, but profit is forecast to decline amid global risks.4403
Q4 2026 - Net sales up, profits down; strong explosives growth; dividend and share buyback increased.4403
Q3 2026 - Profits fell but full-year outlook and shareholder returns were raised on segment growth.4403
Q2 2026 - Net sales rose slightly, but profits declined amid global uncertainty and higher costs.4403
Q1 2026 - Sales and profits climbed in H1 FY2024, with guidance and shareholder returns both increased.4403
Q2 2025 - Strong Q1 profit growth driven by Functional Chemicals; full-year outlook maintained.4403
Q1 2025 - Record profits, higher dividends, and robust capital returns drive future growth.4403
Q4 2025 - Sales and profits rose, driven by Functional Chemicals, with stable outlook and shareholder returns.4403
Q3 2025